These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15988269)

  • 1. The effect of tirofiban on microvascular thrombosis: crush model.
    Yates YJ; Farias CL; Kazmier FR; Puckett CL; Concannon MJ
    Plast Reconstr Surg; 2005 Jul; 116(1):205-8. PubMed ID: 15988269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.
    Chung TL; Pumplin DW; Holton LH; Taylor JA; Rodriguez ED; Silverman RP
    Plast Reconstr Surg; 2007 Oct; 120(5):1281-1288. PubMed ID: 17898601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.
    Singh P; Fu Zhu L; Dziegielewski P; Harris J; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S59-64. PubMed ID: 21453663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
    Rukshin V; Azarbal B; Finkelstein A; Shah PK; Cercek B; Tsang V; Kaul S
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):615-24. PubMed ID: 12658064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
    Rukshin V; Shah PK; Cercek B; Finkelstein A; Tsang V; Kaul S
    Circulation; 2002 Apr; 105(16):1970-5. PubMed ID: 11997285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis and thrombolysis in crushed arteries with or without anastomosis: a new microvascular thrombosis model.
    Chen LE; Seaber AV; Urbaniak JR
    J Reconstr Microsurg; 1996 Jan; 12(1):31-8. PubMed ID: 8618224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparinized irrigating solutions on patency of experimental microvascular anastomoses.
    Zinberg EM; Choo DI; Zotter LA
    Microsurgery; 1989; 10(2):103-7; discussion 108-9. PubMed ID: 2528050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Vivekananthan K; Allie SE; Mitran EV; Chaisson G; Stagg SJ; Allie AA; McElderry MW; Barker EA; Walker CM
    J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
    Rao AK; Sun L; Hiramatsu Y; Gorman JH; Edmunds LH
    Thromb Haemost; 1999 Jul; 82(1):140-4. PubMed ID: 10456468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
    Zhao XQ; Théroux P; Snapinn SM; Sax FL
    Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement by ticlopidine of the inhibitory effect on in vitro platelet aggregation of the glycoprotein IIb/IIIa inhibitor tirofiban.
    Umemura K; Kondo K; Ikeda Y; Nakashima M
    Thromb Haemost; 1997 Nov; 78(5):1381-4. PubMed ID: 9408023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa inhibitors and no-reflow.
    Kloner RA; Dai W
    J Am Coll Cardiol; 2004 Jan; 43(2):284-6. PubMed ID: 14736450
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical heparin enhances patency in a rat model of arterial thrombosis.
    Braam MJ; Cooley BC; Gould JS
    Ann Plast Surg; 1995 Feb; 34(2):148-51; discussion 151-3. PubMed ID: 7741432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
    Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
    Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.